Medpace announces Q4 and FY2023 results; no specific figures available in filing text

Medpace Holdings, Inc.

2023-FY EPS reported $8.88 revenue$1,885,842,000

Press release posted on company website and furnished as Exhibit 99.1, but exhibit text not included in prompt.
Results cover three and twelve months ended December 31, 2023.
Investors should consult the full press release for revenue, EPS, and other metrics.
Company ticker MEDP trades on Nasdaq.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Medpace Holdings, Inc. reported financial results for the three and twelve months ended December 31, 2023.

Period: the three and twelve months ended December 31, 2023
Result: reported results

Exact text from the filing

On February 12, 2024, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three and twelve months ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.